- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05620433
Joint Effort 2.0: a Mobile Application With University Students (JOINTEFFORT)
Joint Effort, a Mobile Prevention and Harm Reduction Application
The purpose of this study is to evaluate quantitatively and qualitatively a mobile application, Joint Effort, targeting safe cannabis use among consumers.
This randomized controlled trial is currently conducted on the Joint Effort mobile application.
Study Overview
Status
Intervention / Treatment
Detailed Description
This online randomized controlled trial with parallel groups is conducted in Quebec (Canada). Interested participants are invited to visit the study's website at www.etudejointeeffort.ca
The study's Website contains text explaining the study. After accepting the conditions and consenting, participants will enroll in the study by providing an email address and a pseudonym. Each participant will be validated through an email address check. After their enrolment, participants will receive a hyperlink via email to invite them to complete a baseline questionnaire.
After completing the baseline questionnaire, participants will be randomly assigned by the computer system either to an experimental group (Joint Effort mobile application) or to a control group (brief normative feedback and standard information).
Four weeks and eight weeks after the baseline questionnaire, participants will complete the online questionnaires again.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Montréal, Quebec, Canada
- Université de Montréal
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged between 18-35 years old
- Be a non-medical cannabis user and have used in the last month
- Understand, read and write French
- Own a smartphone (iPhone)
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Joint Effort mobile application
The Joint Effort mobile application aims to support young adults in taking action on their cannabis use.
Based on the Theory of Planned Behaviour, the content focuses on intention, attitude, and perceived behavioral control.
Various intervention methods and strategies are used to address these determinants (e.g., personalized feedback, persuasive communication, self-observation, and activation of intention).
The objectives include: to allow the individual to become aware (or more aware) of their cannabis use, to support the individual's decision-making process of taking action on their cannabis use, and to guide and support the establishment and sustainability of an action plan.
An optional logbook-type feature (weekly journal of cannabis use) allows personalized monitoring and data collection throughout the course of the intervention.
|
The Joint Effort intervention is available in the form of an iPhone mobile application (running on iOS 13 and higher) in French language.
It aims to support young adults in school who have used cannabis in the past month into taking action on their cannabis use.
|
|
Active Comparator: Brief normative feedback and standard information
The comparator is composed of a brief normative feedback regarding last month's frequency of cannabis use and basic reliable non-personalized information on lower-risk cannabis use (official public websites).
|
The brief normative feedback is based on the frequency of cannabis use.
Participants will also be offered basic reliable non-personalized information on lower-risk cannabis use in the form of official public websites.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Protective Behavioral Strategies for Marijuana (PBSM-17) used
Time Frame: 8 weeks
|
The French version of the questionnaire translated by Côté et al. (2021) will be used.
The 17 items proposed in the scale, each representing a behavioral protection strategy, are measured in terms of frequency of use on a six-point Likert-type scale (never, rarely, occasionally, sometimes, often and always).
As indicated by its developers, the total score of the PBSM-17 is obtained by calculating the total score of each item and then converting this raw score into a standardized form (T-score) ranging from 15 to 73.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in intention to take action on cannabis use
Time Frame: 8 weeks
|
Intention is assessed by three items with a 7 points Likert Scale as recommended by Ajzen (2013): 1) "I intend to take action on my cannabis use within the next month" will be rated on a scale from 1 = strongly disagree to 7 = strongly agree; 2) "Over the next month, the chances of me taking action on my cannabis use are …" will be rated on a scale from 1=very low to 7=very high; 3) "Over the next month, I will be taking action on my cannabis use" will be rated on a scale from 1=very unlikely to 7=very likely.
Intention items scores are tallied for an overall score (range of 3-21).
|
8 weeks
|
|
Cannabis use frequency
Time Frame: 8 weeks
|
The frequency of cannabis use will be assessed using a question previously used in the Quebec (Canada) Survey on Cannabis (2022).
|
8 weeks
|
|
Severity of Dependence
Time Frame: 8 weeks
|
Measured with the Severity of Dependence Scale (SDS) scale (Martin et al., 2006) which includes five items related to compulsive behaviors, concerns, anxiety, and feelings of loss of control in the context of cannabis use.
Four of the items are scored on a Likert-type scale ranging from "never/almost never" (1) to "always" (4) and one item offers a scale ranging from "not difficult" (1) to "impossible" (4).
Severity of dependance items scores are tallied for an overall score (range of 5-20).
|
8 weeks
|
|
Subjective engagement with the developed mobile application (acceptability)
Time Frame: 4 weeks
|
Subjective engagement (self-reported) will be measured using the validated French version (Fontaine et al., 2020) of the User Engagement Scale - Short Form (UES-SF) (O'Brien et al., 2018).
This 12-item instrument serves to measure four dimensions of engagement: 1) aesthetic appeal; 2) focused attention; 3) perceived usability, and 4) reward factor.
Possible answers range from strongly disagree (+1) to strongly agree (+5).
The possible total score ranges between 12 and 60.
The score for each item will be interpreted and the scores for each dimension will be compared to indicate which are rated more highly than others.
|
4 weeks
|
|
Number of screens viewed in the mobile application
Time Frame: 8 weeks
|
Objective data.
This data will be collected automatically when users log into the application.
|
8 weeks
|
|
Total time of use of the mobile application
Time Frame: 8 weeks
|
Objective data.
This data will be collected automatically when users log into the application.
|
8 weeks
|
|
Number of days the mobile application was used
Time Frame: 8 weeks
|
Objective data.
This data will be collected automatically when users log into the application.
|
8 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: José Côté, PhD, Université de Montréal
- Principal Investigator: Didier Jutras-Aswad, MD MSN, Centre de Recherche du Centre Hospitalier de l'Universite de Montreal
- Study Chair: Sylvie Cossette, PhD, Université de Montréal
- Study Chair: Christine Genest, PhD, Université de Montréal
- Study Chair: Shalini Lal, PhD, Université de Montréal
- Study Chair: Judith Lapierre, PhD, Laval University
- Study Chair: Gabrielle Pagé, PhD, Centre de Recherche du Centre Hospitalier de l'Universite de Montreal
- Study Chair: Jingui Cheng, PhD, Université de Montréal
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-11154
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cannabis
-
Anders Fink-Jensen, MD, DMSciNeurobiology Research Unit, RigshospitaletRecruitingCannabis Dependence | Cannabis Abuse | Cannabis Use Disorder | Cannabis Use Disorders | Cannabis AddictionDenmark
-
University of MinnesotaNot yet recruitingCannabis Use | Cannabis Use DisorderUnited States
-
Indiana UniversityNational Institute on Drug Abuse (NIDA)RecruitingMarijuana Abuse | Marijuana Use | Addiction | Substance Use | Cannabis Dependence | Substance Use Disorders | Cannabis Use | Substance Abuse | Addiction, Substance | Marijuana Dependence | Substance Dependence | Marijuana Smoking | Cannabis Abuse | Cannabis Use Disorder | Marijuana | Cannabis Intoxication | Substance Related... and other conditionsUnited States
-
Elias DakwarActive, not recruitingAddiction | Cannabis Dependence | Cannabis Use | Substance Abuse | Cannabis Abuse | Cannabis Use DisorderUnited States
-
Boston Children's HospitalNational Institute on Drug Abuse (NIDA)RecruitingCannabis Use | Cannabis Use Disorder | Cannabis IntoxicationUnited States
-
University of WashingtonNational Institute on Drug Abuse (NIDA)CompletedCannabis Dependence | Cannabis Abuse
-
Yale UniversityRobert E. Leet and Clara Guthrie Patterson Trust Mentored Research AwardCompletedCannabis | Cannabis Use | Cannabis AbuseUnited States
-
Brown UniversityNational Institute on Drug Abuse (NIDA)CompletedCannabis Dependence | Cannabis AbuseUnited States
-
University College, LondonMedical Research Council; InvicroCompletedCannabis | Cannabis Dependence | Cannabis Use | CBD | Adolescent Development | THC | Marijuana | Cannabis IntoxicationUnited Kingdom
-
Stanford UniversityNational Institute on Drug Abuse (NIDA)Not yet recruiting
Clinical Trials on Joint Effort
-
Centre hospitalier de l'Université de Montréal...Recruiting
-
Centre hospitalier de l'Université de Montréal...Completed
-
Kitani, Lenore, PTCompleted
-
Federal University of Health Science of Porto AlegreIrmandade Santa Casa de Misericórdia de Porto AlegreUnknownFatigue | Dyspnea | Muscle Strength | Functional Capacity
-
Universidade Federal do Rio de JaneiroRecruitingWeaning Failure | Mechanical Ventilation Pressure HighBrazil
-
Loewenstein HospitalAriel UniversityUnknownChronic Pain | Traumatic Brain Damage
-
University of New MexicoActive, not recruitingPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)United States
-
University of PittsburghNational Institute on Deafness and Other Communication Disorders (NIDCD); University...RecruitingStroke | AphasiaUnited States
-
University of New MexicoActive, not recruiting
-
University Hospital, ToulouseTerminatedMalignant Mesothelioma | Bronchial CancerFrance